Compare · HEXO vs ZOM
HEXO vs ZOM
Side-by-side comparison of HEXO Corp. (HEXO) and Zomedica Corp. (ZOM): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both HEXO and ZOM operate in Pharmaceuticals and Biotechnology (Health Care), so they compete in similar markets.
- ZOM is the larger of the two at $284.2M, about 1.6x HEXO ($176.3M).
- HEXO has more recent analyst coverage (11 ratings vs 1 for ZOM).
- Company
- HEXO Corp.
- Zomedica Corp.
- Price
- $0.70+3.98%
- $0.10-3.15%
- Market cap
- $176.3M
- $284.2M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Pharmaceuticals and Biotechnology
- Pharmaceuticals and Biotechnology
- Exchange
- NYSE
- AMEX
- IPO
- 2017
- News (4w)
- 0
- 0
- Recent ratings
- 11
- 1
HEXO Corp.
HEXO Corp., through its subsidiaries, produces, markets, and sells cannabis in Canada. It offers dried cannabis under the Time of Day and H2 lines; Elixir, a cannabis oil sublingual mist product line; and Decarb, an activated fine-milled cannabis powder product. The company offers its adult-use and medical products under the HEXO brand name. Additionally, it offers cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brand; and cannabis products under Original Stash and Up brand names. The company was formerly known as The Hydropothecary Corporation and changes its name to HEXO Corp. in August 2018. HEXO Corp. was founded in 2013 and is headquartered in Kanata, Canada.
Zomedica Corp.
Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA, a diagnostic biosensor platform for the detection of thyroid disorders in dogs and cats, and adrenal disorders in dogs. It has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for development and commercialization of novel pathogen detection system. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020. Zomedica Corp. was founded in 2015 and is headquartered in Ann Arbor, Michigan.
Latest HEXO
- Cash Flow Chronicles: Analyst Dissects Canadian Cannabis Balance Sheets, Market Trends Vs. The US
- EXCLUSIVE: Key Insights And 4 Predictions On Cannabis Sector Equity Research For 2024
- SEC Form 15-12G filed by HEXO Corp.
- 'North Carolina Senate Approves Medical Marijuana Regulatory Appointment As House Leader Says 'Heavy-Handed' Tactics Not Helping Legalization's Fate' - Marijuana Moment
- 'Major Marijuana Industry Players Launch Super Pac To Advance Cannabis Reform As 2024 Election Heats Up' - Marijuana Moment
- 'Schumer Touts Marijuana Banking Bill As Bipartisan Priority, And Republican Sponsor Is Optimistic As Long As Measure Isn't Expanded' -Marijuana Moment Report
- Tilray's HEXO Acquisition Creates Canada's Top Cannabis Company With 44% Market Share Boost
- SEC Form 25-NSE filed by HEXO Corp.
- SEC Form F-10POS filed by HEXO Corp.
- SEC Form F-10POS filed by HEXO Corp.
Latest ZOM
- Diality Appoints Peter Donato as Chief Financial Officer
- Zomedica Announces Collaboration with Prime Video as Assisi Loop(R) Products Appear in New Holiday Film Merv
- Zomedica Expands TRUFORMA(R) Diagnostic Menu with Launch of Equine Progesterone Assay
- Zomedica Announces "Friday at Four" Webinar on November 21st Providing Strategic Overview & Third Quarter 2025 Business Review
- Zomedica Achieves ISO 13485 Certification, Underscoring Strengthened Quality Infrastructure and Commercial Potential
- Zomedica Announces Third Quarter 2025 Financial Results: Revenue up 16% to $8.1 Million with 67% Gross Margins and $54 Million in Liquidity to Support Growth
- Zomedica Announces Launch of the Assisi Loop Lounge(R), Scientifically Backed tPEMF(TM) Therapy for Pets
- Zomedica Expands Grovet's Distribution Agreement to Include Zomedica's Diagnostic and Therapeutic Device Products Across the European Union
- Zomedica to Spotlight VETGuardian(R) Zero Touch(TM) Monitor in October "Fourth Friday at Four" Webinar
- Zomedica Expands TRUFORMA(R) Diagnostic Platform with Addition of Feline Use to Cobalamin & Folate Assay